In this regard, Kienle et al. (2005) already reported an upregulation of FOS and a downregulation of BLNK, SYK, CDK4, and TP53 in IGHV1-69 cases compared to M-CLL [44]. This evidence concerns the gene FOS and B-cell chronic lymphocytic leukemia.